Literature DB >> 25377896

Metastatic ovarian carcinoma to the brain: an approach to identification and classification for neuropathologists.

Houman Nafisi1, Matthew Cesari, Jason Karamchandani, Gayathiri Balasubramaniam, Julia Lee Keith.   

Abstract

Brain metastasis is an uncommon but increasing manifestation of ovarian epithelial carcinoma and neuropathologists' collective experience with these tumors is limited. We present clinicopathological characteristics of 13 cases of brain metastases from ovarian epithelial carcinoma diagnosed at two academic institutions. The mean ages at diagnosis of the ovarian carcinoma and their subsequent brain metastases were 58.7 and 62.8 years, respectively. At the time of initial diagnosis of ovarian carcinoma the majority of patients had an advanced stage and none had brain metastases as their first manifestation of malignancy. Brain metastases tended to be multiple with ring-enhancing features on neuroimaging. Primary tumors and their brain metastases were all high-grade histologically and the histologic subtypes were: nine high-grade serous carcinoma (HGSC) cases, two clear cell carcinoma (CCC) cases and a single case each of carcinosarcoma and high-grade adenocarcinoma. A recommended histo- and immunopathological approach to these tumours are provided to aid neuropathologists in the recognition and classification of metastatic ovarian carcinoma to the brain.
© 2014 Japanese Society of Neuropathology.

Entities:  

Keywords:  brain neoplasms; neoplasm metastasis; ovarian neoplasms; serous carcinoma

Mesh:

Year:  2014        PMID: 25377896     DOI: 10.1111/neup.12172

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  5 in total

1.  Downregulation of SASH1 correlates with tumor progression and poor prognosis in ovarian carcinoma.

Authors:  Xiaoyan Ren; Yifei Liu; Yumei Tao; Guoxiang Zhu; Meilan Pei; Jianguo Zhang; Jian Liu
Journal:  Oncol Lett       Date:  2016-03-17       Impact factor: 2.967

2.  Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations.

Authors:  S Balendran; S Liebmann-Reindl; A S Berghoff; T Reischer; N Popitsch; C B Geier; L Kenner; P Birner; B Streubel; M Preusser
Journal:  J Neurooncol       Date:  2017-05-11       Impact factor: 4.130

3.  Brain metastasis from ovarian clear cell carcinoma: A case report.

Authors:  Ping Liu; Wei Liu; Yuhua Feng; Xiangyu Xiao; Meizuo Zhong
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

4.  Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers.

Authors:  Gloria Mittica; Margherita Goia; Angela Gambino; Giulia Scotto; Mattia Fonte; Rebecca Senetta; Massimo Aglietta; Fulvio Borella; Anna Sapino; Dionyssios Katsaros; Furio Maggiorotto; Eleonora Ghisoni; Gaia Giannone; Valentina Tuninetti; Sofia Genta; Chiara Eusebi; Marina Momi; Paola Cassoni; Giorgio Valabrega
Journal:  J Ovarian Res       Date:  2020-05-04       Impact factor: 4.234

Review 5.  Biomarkers of Central Nervous System Involvement from Epithelial Ovarian Cancer.

Authors:  Giulia Scotto; Fulvio Borella; Margherita Turinetto; Valentina Tuninetti; Anna A Valsecchi; Gaia Giannone; Stefano Cosma; Chiara Benedetto; Giorgio Valabrega
Journal:  Cells       Date:  2021-12-03       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.